Literature DB >> 11311901

Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system.

L L Jennings1, C Hao, M A Cabrita, M F Vickers, S A Baldwin, J D Young, C E Cass.   

Abstract

Nucleoside transport processes play an important role in human cells in salvage of nucleosides used in the biosynthesis of nucleic acids and in regulating endogenous adenosine concentrations in the human central nervous system (CNS). By altering the levels of adenosine available to interact with cell-surface receptors, nucleoside transporters have profound effects on the ability of adenosine to modulate neurotransmission, vascular tone and other physiological events. Although the human equilibrative nucleoside transporters 1 and 2 (hENT1 and hENT2) are believed to play a crucial role in modulating brain function, their distribution within the major divisions of the human CNS is not known. In this work, antibodies specific for hENT1 and hENT2 were produced against fragments of the transporter proteins and used for immunoblot analysis of enriched membrane fractions prepared from several regions of the human brain. While hENT1 was most prevalent in the frontal and parietal lobes of the cerebral cortex, thalamus, midbrain and basal ganglia, hENT2 was concentrated in the cerebellum and brainstem regions, particularly the pons. The apparent reciprocal distribution of hENT1 and hENT2 in human brain suggests that these nucleoside transporter proteins are produced in distinct regions of the CNS where they function in nucleoside salvage and/or regulation of exogenous adenosine. Within the brain regions that were investigated, the pattern of hENT1 distribution correlated well with adenosine A(1) receptor abundance. The regional co-localization of hENT1 and A(1) receptor protein suggests an important role of hENT1-mediated transport process in the control of neuromodulatory actions mediated by adenosine A(1) receptors in human brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311901     DOI: 10.1016/s0028-3908(00)00207-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  26 in total

1.  Very low concentrations of ethanol suppress excitatory synaptic transmission in rat visual cortex.

Authors:  Lucas Luong; Nicholas M Bannon; Andrew Redenti; Marina Chistiakova; Maxim Volgushev
Journal:  Eur J Neurosci       Date:  2017-03-27       Impact factor: 3.386

2.  Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.

Authors:  Dan Shan; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Neuroreport       Date:  2012-03-07       Impact factor: 1.837

Review 3.  Implication of the purinergic system in alcohol use disorders.

Authors:  Liana Asatryan; Hyung W Nam; Moonnoh R Lee; Mahesh M Thakkar; M Saeed Dar; Daryl L Davies; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

Review 4.  An essential role for adenosine signaling in alcohol abuse.

Authors:  Christina L Ruby; Chelsea A Adams; Emily J Knight; Hyung Wook Nam; Doo-Sup Choi
Journal:  Curr Drug Abuse Rev       Date:  2010-09

5.  The type 1 equilibrative nucleoside transporter regulates anxiety-like behavior in mice.

Authors:  J Chen; L Rinaldo; S-J Lim; H Young; R O Messing; D-S Choi
Journal:  Genes Brain Behav       Date:  2007-03-21       Impact factor: 3.449

6.  Regional Variations of Spontaneous, Transient Adenosine Release in Brain Slices.

Authors:  Scott T Lee; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2017-11-27       Impact factor: 4.418

7.  ENT1 inhibition attenuates epileptic seizure severity via regulation of glutamatergic neurotransmission.

Authors:  Zucai Xu; Ping Xu; Yalan Chen; Jing Liu; Yanke Zhang; Yaodong Lv; Jing Luo; Min Fang; Jun Zhang; Jing Wang; Kewei Wang; Xuefeng Wang; Guojun Chen
Journal:  Neuromolecular Med       Date:  2014-12-10       Impact factor: 3.843

Review 8.  The equilibrative nucleoside transporter family, SLC29.

Authors:  Stephen A Baldwin; Paul R Beal; Sylvia Y M Yao; Anne E King; Carol E Cass; James D Young
Journal:  Pflugers Arch       Date:  2003-06-28       Impact factor: 3.657

Review 9.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

10.  Nucleoside map of the human central nervous system.

Authors:  Zsolt Kovács; Arpád Dobolyi; Gábor Juhász; Katalin A Kékesi
Journal:  Neurochem Res       Date:  2009-10-24       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.